XML 39 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2016
Jan. 25, 2015
Jan. 26, 2014
Cash flows from operating activities:      
Net income (loss) $ 11,497 $ 27,947 $ (164,466)
Adjustments to reconcile net income (loss) to net cash provided by operating activities, net of effects of acquisitions:      
Depreciation, amortization and impairments 48,932 69,303 94,073
Impairment - goodwill 0 0 116,686
Effect of acquisition fair value adjustments 0 (929) 2,529
Accretion of deferred financing costs and debt discount 1,469 1,083 1,509
Write-off of deferred financing costs and debt discount 0 0 7,093
Deferred income taxes (1,012) 27 29,987
Stock-based compensation 20,468 29,629 24,589
Earn-out liabilities (16,362) 1,391 (654)
Environmental reserve 2,855 (65) 0
Excess tax benefits on stock based compensation 0 (13) (4,220)
Loss (gain) on disposition of property, plant and equipment 23 74 (28)
Changes in assets and liabilities:      
Accounts receivable, net 25,354 (2,968) 2,827
Inventories 10,262 (13,290) 12,238
Prepaid expenses and other assets 619 (5,902) 623
Accounts payable 4,980 (9,077) (11,294)
Accrued liabilities (12,945) 2,562 (2,739)
Deferred revenue 2,780 (1,419) 3,401
Income taxes payable and prepaid taxes 2,611 2,477 1,825
Other liabilities 545 5,330 4,002
Net cash provided by operating activities 102,076 106,160 117,981
Cash flows from investing activities:      
Purchases of available-for-sale investments 0 0 (1,050)
Proceeds from sales and maturities of available-for-sale investments 0 3,674 10,249
Proceeds from sales of property, plant and equipment 0 89 57
Purchase of property, plant and equipment (13,026) (31,755) (37,161)
Purchase of intangible assets 0 (1,100) (3,533)
Purchase of cost method investment (14,630) (7,148) (2,500)
Acquisitions, net of cash acquired (39,171) (4,852) 0
Net cash used in investing activities (66,827) (41,092) (33,938)
Cash flows from financing activities:      
Proceeds from debt issuance, net of discount 35,000 5,000 327,344
Deferred financing cost 0 0 (2,980)
Excess tax benefits on stock based compensation 0 13 4,220
Payments for employee stock-based compensation payroll taxes (6,513) (7,172) (10,522)
Proceeds from exercises of stock options 5,807 8,880 16,398
Repurchase of outstanding common stock (57,311) (40,906) (30,000)
Payment of long term debt (30,750) (43,749) (368,501)
Net cash used in financing activities (53,767) (77,934) (64,041)
Effect of exchange rate increase on cash and cash equivalents 0 0 0
Net (decrease) increase in cash and cash equivalents (18,518) (12,866) 20,002
Cash and cash equivalents at beginning of period 230,328 243,194 223,192
Cash and cash equivalents at end of period 211,810 230,328 243,194
Supplemental disclosure of cash flow information      
Income taxes paid 7,924 4,399 7,227
Interest paid $ 5,732 $ 5,441 $ 8,727